Therefore, this indicates that genetically determined CD5-mediated lymphocyte hyper-reactivity may act as a disease-modifier factor and result in clinical complications of SLE in conjunction with other genetic and/or environmental factors. The gene discussed is CD5; the disease is systemic lupus erythematosus.